Safety of COVID-19 vaccines
By June 1, 2022, there were 38 prophylactic COVID-19 vaccines approved in 197 countries around the world. The ongoing approval of new vaccines and the accumulation of more than a year's worth of data on their use give particular importance to the consolidation and analysis of information on the...
Saved in:
Main Author: | B. K. Romanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2022-12-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/321 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structure of Adverse Events Following Immunisation against Coronavirus Infection (COVID-19) in the Kyrgyz Republic
by: A. A. Zurdinova, et al.
Published: (2022-12-01) -
Short-term adverse events after COVAXIN vaccination in adolescents (15–18 Years) in Northern India: Frequency, predictors, and reporting behavior
by: Sujoy Bose, et al.
Published: (2025-07-01) -
Serious Adverse Events Following COVID 19 Vaccination in India: A Retrospective Study
by: Sruthikrishna Punathukandi, et al.
Published: (2025-01-01) -
ADVERSE EVENTS FOLLOWING PENTAVALENT VACCINE ADMINISTRATION: A DESCRIPTIVE STUDY IN THE INDIAN CONTEXT
by: Roop Sharma, et al.
Published: (2025-05-01) -
Adverse Events Following Vaccination: A Review of Russian and International Terminology
by: A. S. Korovkin, et al.
Published: (2024-04-01)